Clinical Trial Update: Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia [Phase 2, Phase 3]

View source ↗

Summary

The document reports a Phase 2/3 clinical trial update that is currently recruiting, testing a weight-management approach combined with LNG-IUS and Megestrol Ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Endometrial Hyperplasia
• Infertility
• Obesity

Drugs mentioned

• Levonorgestrel-releasing intrauterine system (LNG-IUS) (Levonorgestrel-releasing intrauterine system)
• Megestrol acetate (megestrol acetate)

Snippet

Sponsor: Xiaojun Chen | Conditions: Atypical Endometrial Hyperplasia, Fertility Issues | Phase 2, Phase 3 | Status: RECRUITING